Ripudamanjit Singh MD
Adult Congenital Heart Disease, Interventional Cardiology
Assistant Professor, Internal Medicine, Mayo Medical School
Join to View Full Profile
1025 Marsh StMankato, MN 56001
Phone+1 507-625-4031
Fax+1 507-385-2908
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Ripudamanjit Singh, MD is a cardiologist in Mankato, Minnesota. He is currently licensed to practice medicine in Minnesota, California, and North Dakota. He is an Assistant Professor at Mayo Medical School.
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Interventional Cardiology, 2004 - 2005- Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Cardiovascular Disease, 2000 - 2004
- Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1997 - 2000
Government Medical College AmritsarClass of 1990
Government Medical College PatialaClass of 1990
Certifications & Licensure
CA State Medical License 2005 - Present
MN State Medical License 1999 - 2025
IA State Medical License 1999 - 2005
ND State Medical License 2005 - 2005
American Board of Internal Medicine Cardiovascular Disease- American Board of Internal Medicine Interventional Cardiology
Publications & Presentations
PubMed
- 23 citationsHigh-Sensitivity Cardiac Troponin T for the Detection of Myocardial Injury and Risk Stratification in COVID-19.Laura De Michieli, Olatunde Ola, Jonathan D. Knott, Ashok Akula, Ramila A. Mehta
Clinical Chemistry. 2021-04-16 - 42 citationsEndothelial-derived tissue factor pathway inhibitor regulates arterial thrombosis but is not required for development or hemostasisThomas A. White, Tucker F. Johnson, Natalia Zarzhevsky, Cindy W. Tom, Sinny Delacroix
Blood. 2010-09-09 - 22 citationsFrequency, etiology, treatment, and outcomes of drug-eluting stent thrombosis during one year of follow-up.Gurpreet S. Sandhu, Brendan Doyle, Ripudamanjit Singh, Malcolm R. Bell, John F. Bresnahan
The American Journal of Cardiology. 2007-02-15
